These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 36680805)

  • 1. Neuro-immune crosstalk in depressive symptoms of multiple sclerosis.
    Wang C; Zhou Y; Feinstein A
    Neurobiol Dis; 2023 Feb; 177():106005. PubMed ID: 36680805
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treating depression in multiple sclerosis with antidepressants: A brief review of clinical trials and exploration of clinical symptoms to guide treatment decisions.
    Nathoo N; Mackie A
    Mult Scler Relat Disord; 2017 Nov; 18():177-180. PubMed ID: 29141805
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Depressive symptoms during anorexia nervosa: State of the art and consequences for an appropriate use of antidepressants].
    Leblé N; Radon L; Rabot M; Godart N
    Encephale; 2017 Feb; 43(1):62-68. PubMed ID: 27452149
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The issue of comorbidity in the treatment of panic.
    Dunner DL
    Int Clin Psychopharmacol; 1998 Apr; 13 Suppl 4():S19-24. PubMed ID: 9690961
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of medical comorbid disease on antidepressant treatment of major depressive disorder.
    Iosifescu DV; Bankier B; Fava M
    Curr Psychiatry Rep; 2004 Jun; 6(3):193-201. PubMed ID: 15142472
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neuroprotective Benefits of Antidepressants in Multiple Sclerosis: Are We Missing the Mark?
    Grech LB; Butler E; Stuckey S; Hester R
    J Neuropsychiatry Clin Neurosci; 2019; 31(4):289-297. PubMed ID: 30945589
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multiple sclerosis and bipolar disorders: the burden of comorbidity and its consequences on quality of life.
    Carta MG; Moro MF; Lorefice L; Picardi A; Trincas G; Fenu G; Cocco E; Floris F; Bessonov D; Akiskal HS; Marrosu MG
    J Affect Disord; 2014; 167():192-7. PubMed ID: 24995886
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Major depression and comorbid substance use disorders.
    Davis L; Uezato A; Newell JM; Frazier E
    Curr Opin Psychiatry; 2008 Jan; 21(1):14-8. PubMed ID: 18281835
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Does the presence of multiple sclerosis impact on symptom profile in depressed patients?
    Boeschoten RE; Schaakxs R; Dekker J; Uitdehaag BMJ; Beekman ATF; Smit JH; Penninx BWJH; van Oppen P
    J Psychosom Res; 2017 Dec; 103():70-76. PubMed ID: 29167049
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antidepressant use in multiple sclerosis: epidemiologic study of a large community sample.
    Cetin K; Johnson KL; Ehde DM; Kuehn CM; Amtmann D; Kraft GH
    Mult Scler; 2007 Sep; 13(8):1046-53. PubMed ID: 17623732
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of antidepressant use between subjects with bipolar disorder and major depressive disorder with or without comorbid anxiety.
    Schaffer A; Cairney J; Veldhuizen S; Cheung A; Levitt A
    J Clin Psychiatry; 2007 Nov; 68(11):1785-92. PubMed ID: 18052573
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Agitated "unipolar" depression re-conceptualized as a depressive mixed state: implications for the antidepressant-suicide controversy.
    Akiskal HS; Benazzi F; Perugi G; Rihmer Z
    J Affect Disord; 2005 Apr; 85(3):245-58. PubMed ID: 15780694
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diagnostic accuracy for major depression in multiple sclerosis using self-report questionnaires.
    Fischer A; Fischer M; Nicholls RA; Lau S; Poettgen J; Patas K; Heesen C; Gold SM
    Brain Behav; 2015 Sep; 5(9):e00365. PubMed ID: 26445703
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Depression comorbidity and antidepressant use in veterans with chronic hepatitis C: results from a retrospective chart review.
    Nelligan JA; Loftis JM; Matthews AM; Zucker BL; Linke AM; Hauser P
    J Clin Psychiatry; 2008 May; 69(5):810-6. PubMed ID: 18426262
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of age on depressive symptomatology and response to antidepressant treatment in patients with major depressive disorder aged 18 to 65 years.
    Wagner S; Wollschläger D; Dreimüller N; Engelmann J; Herzog DP; Roll SC; Tadić A; Lieb K
    Compr Psychiatry; 2020 May; 99():152170. PubMed ID: 32146314
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Use of antidepressant drugs in schizophrenic patients with depression].
    Micallef J; Fakra E; Blin O
    Encephale; 2006; 32(2 Pt 1):263-9. PubMed ID: 16910628
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mirtazapine in comorbid major depression and an alcohol use disorder: A double-blind placebo-controlled pilot trial.
    Cornelius JR; Chung T; Douaihy AB; Kirisci L; Glance J; Kmiec J; FitzGerald D; Wesesky MA; Salloum I
    Psychiatry Res; 2016 Aug; 242():326-330. PubMed ID: 27327217
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comorbid alcohol and substance abuse dependence in depression: impact on the outcome of antidepressant treatment.
    Ostacher MJ
    Psychiatr Clin North Am; 2007 Mar; 30(1):69-76. PubMed ID: 17362804
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Plasma insulin-like growth factor I levels are higher in depressive and anxiety disorders, but lower in antidepressant medication users.
    Bot M; Milaneschi Y; Penninx BW; Drent ML
    Psychoneuroendocrinology; 2016 Jun; 68():148-55. PubMed ID: 26974499
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The association of race, comorbid anxiety, and antidepressant adherence among Medicaid enrollees with major depressive disorder.
    Wu CH; Erickson SR; Piette JD; Balkrishnan R
    Res Social Adm Pharm; 2012; 8(3):193-205. PubMed ID: 21955808
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.